Jpmorgan Healthcare Leaders Etf Probability Of Bankruptcy
| JDOC Etf | 56.92 0.55 0.98% |
JPMorgan |
JPMorgan Healthcare Leaders ETF probability of distress Analysis
JPMorgan Healthcare's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current JPMorgan Healthcare Probability Of Bankruptcy | Less than 9% |
Most of JPMorgan Healthcare's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JPMorgan Healthcare Leaders is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of JPMorgan Healthcare probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting JPMorgan Healthcare odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of JPMorgan Healthcare Leaders financial health.
The market value of JPMorgan Healthcare is measured differently than its book value, which is the value of JPMorgan that is recorded on the company's balance sheet. Investors also form their own opinion of JPMorgan Healthcare's value that differs from its market value or its book value, called intrinsic value, which is JPMorgan Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JPMorgan Healthcare's market value can be influenced by many factors that don't directly affect JPMorgan Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JPMorgan Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if JPMorgan Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JPMorgan Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, JPMorgan Healthcare Leaders has a Probability Of Bankruptcy of 9.0%. This is much higher than that of the family and significantly higher than that of the Health category. The probability of bankruptcy for all United States etfs is notably lower than that of the firm.
JPMorgan Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JPMorgan Healthcare's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of JPMorgan Healthcare could also be used in its relative valuation, which is a method of valuing JPMorgan Healthcare by comparing valuation metrics of similar companies.JPMorgan Healthcare is currently under evaluation in probability of bankruptcy as compared to similar ETFs.
About JPMorgan Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JPMorgan Healthcare Leaders's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JPMorgan Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JPMorgan Healthcare Leaders based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether JPMorgan Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of JPMorgan Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jpmorgan Healthcare Leaders Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Jpmorgan Healthcare Leaders Etf:Check out JPMorgan Healthcare Piotroski F Score and JPMorgan Healthcare Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
The market value of JPMorgan Healthcare is measured differently than its book value, which is the value of JPMorgan that is recorded on the company's balance sheet. Investors also form their own opinion of JPMorgan Healthcare's value that differs from its market value or its book value, called intrinsic value, which is JPMorgan Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JPMorgan Healthcare's market value can be influenced by many factors that don't directly affect JPMorgan Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JPMorgan Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if JPMorgan Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JPMorgan Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.